Literature DB >> 21378271

Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase.

Shideh Kazerounian1, Mark Duquette, Millys A Reyes, James T Lawler, Keli Song, Carole Perruzzi, Luca Primo, Roya Khosravi-Far, Federico Bussolino, Isaac Rabinovitz, Jack Lawler.   

Abstract

CD36 plays a critical role in the inhibition of angiogenesis through binding to the type 1 repeats of thrombospondin-1 (TSP-1) and activating Fyn tyrosine kinase and MAPK pathways. Here, we reveal a novel association of CD36 with VEGFR-2 and spleen tyrosine kinase (Syk). We also address the correlation between the expression of CD36 and Syk by demonstrating that overexpression of CD36 in HUVECs up-regulates endogenous Syk expression. We also define a new role for TSP-1 and CD36 in the activation of the VEGFR-2 signaling pathway that requires Syk. Our findings also identify a role for Syk as a stimulator of VEGF-A-induced angiogenesis by increasing phosphorylation of Y1175 in VEGFR-2, which is a major tyrosine for promoting VEGF-A-induced endothelial cell migration. Together, these studies introduce a new signaling pathway for TSP-1, CD36, and Syk, and address the role of these proteins in regulating the angiogenic switch.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21378271      PMCID: PMC3099580          DOI: 10.1182/blood-2010-09-305284

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  48 in total

1.  c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1.

Authors:  B Jiménez; O V Volpert; F Reiher; L Chang; A Muñoz; M Karin; N Bouck
Journal:  Oncogene       Date:  2001-06-07       Impact factor: 9.867

Review 2.  VEGF receptor signalling - in control of vascular function.

Authors:  Anna-Karin Olsson; Anna Dimberg; Johan Kreuger; Lena Claesson-Welsh
Journal:  Nat Rev Mol Cell Biol       Date:  2006-05       Impact factor: 94.444

Review 3.  Tetraspanin functions and associated microdomains.

Authors:  Martin E Hemler
Journal:  Nat Rev Mol Cell Biol       Date:  2005-10       Impact factor: 94.444

4.  Combined chemical and enzymatic stable isotope labeling for quantitative profiling of detergent-insoluble membrane proteins isolated using Triton X-100 and Brij-96.

Authors:  Josip Blonder; Li-Rong Yu; Galina Radeva; King C Chan; David A Lucas; Timothy J Waybright; Haleem J Issaq; Frances J Sharom; Timothy D Veenstra
Journal:  J Proteome Res       Date:  2006-02       Impact factor: 4.466

5.  The association between CD36 and Lyn protein tyrosine kinase is mediated by lipid.

Authors:  Rick F Thorne; Estelle G Law; Craig A Elith; Kylie J Ralston; Richard C Bates; Gordon F Burns
Journal:  Biochem Biophys Res Commun       Date:  2006-10-06       Impact factor: 3.575

6.  VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing.

Authors:  Susana Constantino Rosa Santos; Cláudia Miguel; Ines Domingues; Angelo Calado; Zhenping Zhu; Yan Wu; Sérgio Dias
Journal:  Exp Cell Res       Date:  2007-03-01       Impact factor: 3.905

7.  Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice.

Authors:  Yoshiko Sakurai; Kaori Ohgimoto; Yuki Kataoka; Nobuaki Yoshida; Masabumi Shibuya
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-11       Impact factor: 11.205

8.  Identification of CD36 molecular features required for its in vitro angiostatic activity.

Authors:  Luca Primo; Chiara Ferrandi; Cristina Roca; Serena Marchiò; Laura di Blasio; Massimo Alessio; Federico Bussolino
Journal:  FASEB J       Date:  2005-07-21       Impact factor: 5.191

9.  Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis.

Authors:  Nicholas E Vlahakis; Bradford A Young; Amha Atakilit; Anne E Hawkridge; Rachel B Issaka; Nancy Boudreau; Dean Sheppard
Journal:  J Biol Chem       Date:  2007-03-14       Impact factor: 5.157

10.  Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments.

Authors:  Maria Grazia Lampugnani; Fabrizio Orsenigo; Maria Cristina Gagliani; Carlo Tacchetti; Elisabetta Dejana
Journal:  J Cell Biol       Date:  2006-08-07       Impact factor: 10.539

View more
  31 in total

1.  The impact of tumor receptor heterogeneity on the response to anti-angiogenic cancer treatment.

Authors:  Ding Li; Stacey D Finley
Journal:  Integr Biol (Camb)       Date:  2018-04-23       Impact factor: 2.192

2.  LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.

Authors:  Bin Ren; Brad Best; Devi Prasadh Ramakrishnan; Brian P Walcott; Peter Storz; Roy L Silverstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-24       Impact factor: 8.311

Review 3.  Integration of pro- and anti-angiogenic signals by endothelial cells.

Authors:  Shideh Kazerounian; Jack Lawler
Journal:  J Cell Commun Signal       Date:  2017-12-20       Impact factor: 5.782

Review 4.  Protein kinases and associated pathways in pluripotent state and lineage differentiation.

Authors:  Melina Shoni; Kathy O Lui; Demetrios G Vavvas; Michael G Muto; Ross S Berkowitz; Nikolaos Vlahos; Shu-Wing Ng
Journal:  Curr Stem Cell Res Ther       Date:  2014       Impact factor: 3.828

5.  Thrombospondin-1 modulates VEGF signaling via CD36 by recruiting SHP-1 to VEGFR2 complex in microvascular endothelial cells.

Authors:  Ling-Yun Chu; Devi Prasadh Ramakrishnan; Roy L Silverstein
Journal:  Blood       Date:  2013-07-29       Impact factor: 22.113

6.  Anti-angiogenesis effect of 3'-sulfoquinovosyl-1'-monoacylglycerol via upregulation of thrombospondin 1.

Authors:  Kayo Matsuki; Atsushi Tanabe; Ayumi Hongo; Fumio Sugawara; Kengo Sakaguchi; Nobuaki Takahashi; Noriyuki Sato; Hiroeki Sahara
Journal:  Cancer Sci       Date:  2012-06-20       Impact factor: 6.716

7.  Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling.

Authors:  Dmitri Samovski; Pallavi Dhule; Terri Pietka; Miriam Jacome-Sosa; Eric Penrose; Ni-Huiping Son; Charles Robb Flynn; Kooresh I Shoghi; Krzysztof L Hyrc; Ira J Goldberg; Eric R Gamazon; Nada A Abumrad
Journal:  Diabetes       Date:  2018-05-10       Impact factor: 9.461

Review 8.  Spleen tyrosine kinase inhibitors for rheumatoid arthritis: where are we now?

Authors:  Ian C Scott; David L Scott
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

9.  Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.

Authors:  Katie S Wraith; Simbarashe Magwenzi; Ahmed Aburima; Yichuan Wen; David Leake; Khalid M Naseem
Journal:  Blood       Date:  2013-05-22       Impact factor: 22.113

10.  Thrombospondin-1/CD36 pathway contributes to bone marrow-derived angiogenic cell dysfunction in type 1 diabetes via Sonic hedgehog pathway suppression.

Authors:  Jie-Mei Wang; Jeffery S Isenberg; Timothy R Billiar; Alex F Chen
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-10-22       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.